[ET Net News Agency, 6 March 2026] DUALITYBIO-B (09606) rose 10.7% to HK$322.4.
It hits an intra-day high of HK$322.4, breaking above the 10-D SMA of HK$314.94, and an intra-day low of HK$281.2. The total shares traded was 1.25 million, with a value of HK$385.54m. The active buy/sell ratio is 66:34, with net buying turnover of HK$121.5m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$36.91m, with volume weighted average price of HK$308.977. UBS accounts for greatest net responsive selling turnover of HK$54.38m, with volume weighted average price of HK$309.498. The stock has risen a combined 13.1% over the past 2 consecutive trading days.
Basic Information| Nominal | 322.400 | % Chg | +10.71% |
| High | 322.400 | Low | 281.200 |
| Shares Tr | 1.25m | Turnover | 385.54m |
| 10-D SMA | 314.940 | %H.V | 42.567 |
| 20-D SMA | 322.690 | VWAP | 309.218 |
| 50-D SMA | 330.096 | RSI14 | 50.142 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 66:34, with net buying turnover of HK$121.5m, rising a combined 13.1% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| DUALITYBIO-B (09606) | 322.40 | +10.71 |
| HUTCHMED (00013) | 22.06 | +4.75 |
| INNOVENT BIO (01801) | 83.30 | +6.18 |
| XTALPI (02228) | 10.07 | +3.49 |
| WUXI BIO (02269) | 35.58 | +0.40 |
| WUXI APPTEC (02359) | 111.60 | +2.86 |
| TRANSTHERA-B (02617) | 87.60 | +36.66 |
| BEONE MEDICINES (06160) | 182.40 | +2.70 |
| AKESO (09926) | 107.00 | +4.90 |
| REMEGEN (09995) | 85.45 | +11.12 |
(ed)
Nominal 
